3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
95
NIH
60
INDUSTRY
14
OTHER_GOV
5
NETWORK
5
INDIV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Retroperitoneal liposarcoma
1
Liposarcoma
1
Leiomyosarcoma
1
Chondrosarcoma
1
Interventions
Tacrolimus
2
Pyridostigmine Bromide
2
Proflavine
2
Prednisone
2
plerixafor
1
olaparib
1
nilotinib
1
ethyl pyruvate
1
compound W
1
Uracil
1
Tegafur
1
Surgical Procedures, Operative
1
Steroids
1
Salicylates
1
PM 01183
1
Mycophenolic Acid
1
Methylprednisolone
1
Methotrexate
1
Immunosuppressive Agents
1
Immunoglobulins, Intravenous
1
Doxorubicin
1
Darbepoetin alfa
1
Cyclosporine
1
Cyclophosphamide
1
Curettage
1
Circumcision, Male
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
INDIV
×
Doxorubicin
×
Clear all
NCT02587169
2015-10-27
GEIS-27
Broto, Javier MartÃn, M.D.
Phase 1/2
Unknown
40 enrolled